Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human T-cell leukemia virus type 1 (HTLV-1) envelope glycoprotein gp46 is the surface (SU) subunit responsible for viral attachment and entry into host T-cells. Within gp46, the central proline-rich region (PRR) serves as a critical flexible linker between the N-terminal receptor-binding domain and the C-terminal domain (UniProt P03381). This region is essential for transmitting the signal of receptor binding to the transmembrane subunit (gp21), thereby triggering the conformational changes required for membrane fusion (Garrus et al., J Virol, 2000). As a highly conserved and immunodominant segment, the PRR is a major target for neutralizing antibodies that can block viral infection and syncytium formation (Pique et al., J Virol, 1992). Therapeutic strategies focusing on this region include the development of monoclonal antibodies and subunit vaccines intended to prevent or treat HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and Adult T-cell leukemia/lymphoma (ATL) (Kim et al., J Biol Chem, 2004).
Neutralization of viral particles, inhibition of viral entry into host cells, and prevention of syncytia formation by blocking conformational changes required for membrane fusion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human T-cell leukemia virus type 1 envelope glycoprotein gp46 proline-rich region (HTLV-1 gp46 PRR).